87 related articles for article (PubMed ID: 15731862)
1. Design and synthesis of inositolphosphoglycan putative insulin mediators.
López-Prados J; Cuevas F; Reichardt NC; de Paz JL; Morales EQ; Martín-Lomas M
Org Biomol Chem; 2005 Mar; 3(5):764-86. PubMed ID: 15731862
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of inositol phosphoglycan with prostaglandylinositol cyclic phosphate, two potential mediators of insulin action.
Wasner HK; Müller G; Eckel J
Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):358-63. PubMed ID: 14520603
[TBL] [Abstract][Full Text] [Related]
3. [Advances in the research on insulin mediators].
Guo KQ
Zhonghua Yi Xue Za Zhi; 1993 Jan; 73(1):54-6. PubMed ID: 8389235
[No Abstract] [Full Text] [Related]
4. Circulating factors and insulin resistance. II. The action of the novel myo-inositol cyclic 1,2-inositol phosphate phosphoglycan insulin antagonist from human plasma in regulating pyruvate dehydrogenase phosphatase.
Galasko GT; Abe S; Lilley K; Zhang C; Larner J
J Clin Endocrinol Metab; 1996 Mar; 81(3):1051-7. PubMed ID: 8772575
[TBL] [Abstract][Full Text] [Related]
5. Convenient synthesis of 3- and 6-deoxy-D-myo-inositol phosphate analogues from (+)-epi- and (-)-vibo-quercitols.
Ogawa S; Tezuka Y
Bioorg Med Chem Lett; 2006 Oct; 16(19):5238-43. PubMed ID: 16904317
[TBL] [Abstract][Full Text] [Related]
6. [Myoinositol--alternative treatment of insulin resistance in adolescents].
Kedikova S; Sirakov M; Boyadzhieva M
Akush Ginekol (Sofiia); 2011; 50(7):16-9. PubMed ID: 22452173
[TBL] [Abstract][Full Text] [Related]
7. Inositolphosphoglycan mediators structurally related to glycosyl phosphatidylinositol anchors: synthesis, structure and biological activity.
Martín-Lomas M; Khiar N; García S; Koessler JL; Nieto PM; Rademacher TW
Chemistry; 2000 Oct; 6(19):3608-21. PubMed ID: 11072827
[TBL] [Abstract][Full Text] [Related]
8. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation.
Kim C; Cheng CY; Saldanha SA; Taylor SS
Cell; 2007 Sep; 130(6):1032-43. PubMed ID: 17889648
[TBL] [Abstract][Full Text] [Related]
9. Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.
Knoechel TR; Tucker AD; Robinson CM; Phillips C; Taylor W; Bungay PJ; Kasten SA; Roche TE; Brown DG
Biochemistry; 2006 Jan; 45(2):402-15. PubMed ID: 16401071
[TBL] [Abstract][Full Text] [Related]
10. [The role of phospho-oligosaccharides as secondary mediators in the action of insulin].
Mitev V; Sirakov L
Eksp Med Morfol; 1990; 29(3):61-7. PubMed ID: 2276381
[No Abstract] [Full Text] [Related]
11. D-chiro-inositol in insulin action and insulin resistance-old-fashioned biochemistry still at work.
Larner J
IUBMB Life; 2001 Mar; 51(3):139-48. PubMed ID: 11547915
[No Abstract] [Full Text] [Related]
12. Insulin second messengers.
Strålfors P
Bioessays; 1997 Apr; 19(4):327-35. PubMed ID: 9136630
[TBL] [Abstract][Full Text] [Related]
13. Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes.
Zhang J; Hupfeld CJ; Taylor SS; Olefsky JM; Tsien RY
Nature; 2005 Sep; 437(7058):569-73. PubMed ID: 16177793
[TBL] [Abstract][Full Text] [Related]
14. An anionic inositol phosphate glycan pseudotetrasaccharide exhibits high insulin-mimetic activity in rat adipocytes.
Chakraborty N; d'Alarcao M
Bioorg Med Chem; 2005 Dec; 13(24):6732-41. PubMed ID: 16115771
[TBL] [Abstract][Full Text] [Related]
15. Dynamic binding of PKA regulatory subunit RI alpha.
Gullingsrud J; Kim C; Taylor SS; McCammon JA
Structure; 2006 Jan; 14(1):141-9. PubMed ID: 16407073
[TBL] [Abstract][Full Text] [Related]
16. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
Frembgen-Kesner T; Elcock AH
J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
[TBL] [Abstract][Full Text] [Related]
17. Catalytic independent functions of a protein kinase as revealed by a kinase-dead mutant: study of the Lys72His mutant of cAMP-dependent kinase.
Iyer GH; Garrod S; Woods VL; Taylor SS
J Mol Biol; 2005 Sep; 351(5):1110-22. PubMed ID: 16054648
[TBL] [Abstract][Full Text] [Related]
18. Specificity determinants in inositol polyphosphate synthesis: crystal structure of inositol 1,3,4-trisphosphate 5/6-kinase.
Miller GJ; Wilson MP; Majerus PW; Hurley JH
Mol Cell; 2005 Apr; 18(2):201-12. PubMed ID: 15837423
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
20. Definition of an electrostatic relay switch critical for the cAMP-dependent activation of protein kinase A as revealed by the D170A mutant of RIalpha.
Abu-Abed M; Das R; Wang L; Melacini G
Proteins; 2007 Oct; 69(1):112-24. PubMed ID: 17596845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
